alaproclate (Compound)

Synonyms:Alaproclate, 60719-82-6, GEA 654, (S)-alaproclate, GEA-654, [1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate, NSC-758657, CHEMBL36591, DL-Alanine, 2-(4-chlorophenyl)-1,1-dimethylethyl ester, DTXSID5045122, C4R42570ZO, NCGC00015012-02, DTXCID3025122, Alaproclato, Alaproclatum, MLS002153522, Alaproclate [USAN:INN], Alaproclatum [INN-Latin], Alaproclato [INN-Spanish], CAS-60719-82-6, SMR001230852, UNII-C4R42570ZO, SR-01000075538, DL-Alanin 4-chlor-alpha,alpha-dimethylphenethylester, DL-Alanine p-chloro-alpha,alpha-dimethylphenethyl ester, [1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate;hydrochloride, 1-(4-Chlorophenyl)-2-methylpropan-2-yl 2-aminopropanoate hydrochloride, Spectrum_001468, 4-Chlor-alpha,alpha-dimethylphenethyl (RS)-2-aminopropionat, SpecPlus_000836, Spectrum2_001653, Spectrum3_001626, Spectrum4_000594, Spectrum5_001309, ALAPROCLATE [INN], Alaproclate (USAN/INN), ALAPROCLATE [USAN], ALAPROCLATE [MART.], Lopac0_000127, SCHEMBL34357, ALAPROCLATE [WHO-DD], BSPBio_003291, KBioGR_001088, KBioSS_001948, DivK1c_006932, SPECTRUM1504136, SPBio_001805, BDBM76298, CHEBI:91544, KBio1_001876, KBio2_001948, KBio2_004516, KBio2_007084, KBio3_002511, cid_11957454, HMS1922D07, Pharmakon1600-01504136, Tox21_110066, CCG-39071, NSC758657, Tox21_110066_1, DB13233, NSC 758657, SDCCGSBI-0050115.P004, NCGC00015012-03, NCGC00015012-04, NCGC00015012-05, NCGC00015012-06, NCGC00015012-07, NCGC00015012-09, NCGC00015012-10, NCGC00095103-01, NCGC00095103-02, NCGC00095103-03, NCGC00095103-04, SBI-0050115.P003, DB-114156, D02787, Q4708345, SR-01000075538-3, BRD-A14966924-001-03-0, 1-(4-chlorophenyl)-2-methylpropan-2-yl 2-aminopropanoate, DL-ALANINE P-CHLORO-.ALPHA.,.ALPHA.-DIMETHYLPHENETHYL ESTER., [1-(4-chlorophenyl)-2-methyl-propan-2-yl] 2-azanylpropanoate;hydrochloride, 2-aminopropanoic acid [1-(4-chlorophenyl)-2-methylpropan-2-yl] ester;hydrochloride, 2-aminopropionic acid [2-(4-chlorophenyl)-1,1-dimethyl-ethyl] ester;hydrochloride

Pubchem:PUBCHEM:2081

Id:91fe79f6-70dd-5cef-9c81-bd6fec154b19

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View alaproclate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for alaproclate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with alaproclate.

Results found

Linked to

	Label	Description
	BRD-A14966924-001-03-0 Substance (Entity type)	A Substance
	alaproclate (fb40a663-c9e4-456b-a85d-257af4e29fcc) Collection (Entity type)	Metadatata for alaproclate
	aloxistatin in similarity relationship with alaproclate Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	probenecid in similarity relationship with alaproclate Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alaproclate negatively regulates MAP7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alaproclate positively regulates RGCC Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alaproclate in similarity relationship with Bemegride Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alaproclate negatively regulates EDEM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alaproclate negatively regulates APOD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alaproclate positively regulates SELENOP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS